"I have tremendous confidence in the many scientists, inspectors, and staff at the FDA to help accomplish these goals and am excited to work with them," said new FDA commissioner Dr Marty Makary.

Research and development expenses for the first quarter of 2025 were $42.9 million versus $20.7 million for the comparable ...

An under-the-radar court ruling may be among the most significant harbingers of the crises to come for the FDA and public ...

Key insights include the rise of precision medicine, regulatory compliance, and the significant contributions of major players like BASF and Johnson Matthey. Get comprehensive data and competitive ...

In an interview, FDA Commissioner Marty Makary opened up about his first weeks on the job and his vision for the future.